Towards tailored dialysis fluids in CAPD--the role of reduced calcium and magnesium in dialysis fluids
Hutchison, A.J.; Gokal, R.
Peritoneal Dialysis International Journal of the International Society for Peritoneal Dialysis 12(2): 199-203
1992
ISSN/ISBN: 0896-8608 PMID: 1586680 Document Number: 404128
Document emailed within 1 workday
Related Documents
Hutchison, A.J.; Merchant, M.; Boulton, H.F.; Hinchcliffe, R.; Gokal, R. 1993: Calcium and magnesium mass transfer in peritoneal dialysis patients using 1.25 mmol/L calcium, 0.25 mmol/L magnesium dialysis fluid Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 13(3): 219-223Ward, R.A. 2011: New AAMi standards for dialysis fluids Nephrology News and Issues 25(13): 33-36
Bousquet, B.; Aubry, J.P.; Bouvier, J.L.; Dreux, C. 1972: Autoanalysis of urea without dialysis in biological fluids Pathologie-Biologie 20(3): 213-218
Pagliari, B.; Baretta, A.; De Cristofaro, V.; Samà, F.; Cantaluppi, A.; Martis, L.; Imbasciati, E. 1991: Short-term effects of low-calcium dialysis solutions on calcium mass transfer, ionized calcium, and parathyroid hormone in CAPD patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 11(4): 326-329
Alloatti, S.; Bonfant, G.; Belfanti, P.; Pellu, V. 2004: The purity of dialysis fluids: Guidelines of Piedmont and Aosta Valley Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 21 Suppl. 30: S36-S41
Wieslander, A.; Linden, T.; Kjellstrand, P. 2001: Glucose degradation products in peritoneal dialysis fluids: how they can be avoided Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S119-S124
Linden, T.; Forsbäck, G.; Deppisch, R.; Henle, T.; Wieslander, A. 1998: 3-Deoxyglucosone, a promoter of advanced glycation end products in fluids for peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 18(3): 290-293
Tkachuk, V.V. 1979: Calcium and magnesium content in the tissues and biological fluids of intact rats with chronic pharmacological sympathectomy Farmatsevtychnyi Zhurnal 2: 58-61
Wieslander, A.P.; Kjellstrand, P.T.; Rippe, B. 1995: Heat sterilization of glucose-containing fluids for peritoneal dialysis: biological consequences of chemical alterations Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 15(7 Suppl): S52
Canaud, B.; Mion, C. 1995: Role of continuous ambulatory peritoneal dialysis (CAPD) in a program for the treatment of chronic renal insufficiency. Problems posed by transfer of CAPD to transplantation or hemodialysis Nephrologie 16(1): 129-135
Rafiee-Tehrani, M.; Farrokhnia, R.; Falkenhagen, D.; Weber, C. 1996: Removal of lipid a and Pseudomonas aeruginosa endotoxin from dialysis fluids by high-flux polysulfone ultrafilter (dialyzer) PDA Journal of Pharmaceutical Science and Technology 50(5): 306-310
Choi, H.Y.; Kim, D.K.; Lee, T.H.; Moon, S.J.; Han, S.H.; Lee, J.E.; Kim, B.S.; Park, H.C.; Choi, K.H.; Ha, S.K.; Han, D.-S.; Lee, H.Y. 2008: The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28(2): 174-182
Kanjanabuch, T.; Puttipittayathorn, N.; Leelahavanichkul, A.; Lieusuwan, S.; Katavetin, P.; Mahatanan, N.; Sriudom, K.; Chirananthavat, T.; Thongbor, N.; Eiam-Ong, S. 2011: Exfoliated mesothelial cell and CA-125 in automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD) patients Journal of the Medical Association of Thailand 94(Suppl 4): S119-S125
Kumano, K.; Kawaguchi, Y. 2000: Multicenter cross-sectional study for dialysis dose and physician's subjective judgment in Japanese peritoneal dialysis patients. Group for the Water and Electrocyte Balance Study in CAPD American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 35(3): 515-525
Zwiech, R.ł; Dryja, P.ła.; Łacina, D.; Króliczak, V.; Chrul, S.ła.; Kacprzyk, F. 2011: The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients Wiadomosci Lekarskie 64(1): 9-14
Apostolou, T.; Tziamalis, M.; Christodoulidou, C.; Fountas, P.; Billis, A. 1998: Regression of massive tumoral calcinosis of the ischium in a dialysis patient after treatment with reduced calcium dialysate and i.v. administration Clinical Nephrology 50(4): 247-251
Chan, M.K. 1984: Peritoneal dialysis--a review with consideration of the role of CAPD in renal replacement therapy in developing countries Singapore Medical Journal 25(4): 212-215
Dogukan, A.; Oymak, F.S.; Taskapan, H.; Güven, M.; Tokgoz, B.; Utas, C. 2001: Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration Clinical Nephrology 55(2): 181-182
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Mehrotra, R.; Nolph, K.D.; Gotch, F. 1997: Early initiation of chronic dialysis: role of incremental dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(5): 426-430